Open Innovation Drug Discovery

Sample Logistics

When compound structures pass in silico evaluation and are accepted for biological evaluation, participating investigators will submit a 3-5 mg physical sample of the compound. Lilly provides barcoded vials and shipping as an in-kind service to participants.


Compound samples submitted for screening should be at least 90% pure based on contemporary analytical characterization.

Investigators are responsible for following all international shipping rules.

Upon receipt of the compound samples, Lilly tests biological activity in a battery of assay modules. Participant investigators may access detailed sample logistics and shipping information through their personal OIDD accounts.